This list is based on the watchlists of people on Stock Events who follow RASP. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Actavia Life Sciences, Inc. is a biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It also develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.
Show more...
FAQ
What is Actavia Life Sciences stock price today?▼
The current price of RASP is $0 USD — it has increased by +0% in the past 24 hours. Watch Actavia Life Sciences stock price performance more closely on the chart.
What is Actavia Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Actavia Life Sciences stocks are traded under the ticker RASP.
What is Actavia Life Sciences market cap?▼
Today Actavia Life Sciences has the market capitalization of 385,905.5
What were Actavia Life Sciences earnings last quarter?▼
RASP earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Actavia Life Sciences revenue for the last year?▼
Actavia Life Sciences revenue for the last year amounts to 0 USD.
What is Actavia Life Sciences net income for the last year?▼
RASP net income for the last year is -8.89M USD.
How many employees does Actavia Life Sciences have?▼
As of April 01, 2026, the company has 1 employees.
In which sector is Actavia Life Sciences located?▼
Actavia Life Sciences operates in the Health Care sector.
When did Actavia Life Sciences complete a stock split?▼
The last stock split for Actavia Life Sciences was on September 20, 2016 with a ratio of 3.25:1.
Where is Actavia Life Sciences headquartered?▼
Actavia Life Sciences is headquartered in New York, US.